University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 24 of 27
Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma
NCT00794950
Rectal Indomethacin in the Prevention of Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis in High Risk Patients
NCT00820612
Evaluation of Radiology Resident Anxiety When Beginning Emergency Room (ER) Call
NCT00859066
Positional Therapy After Stroke
NCT01047709
Role of Exercise in Diastolic Heart Failure
NCT01047631
Imaging of Soft Tissues
NCT00796094
Risk Factors for Implant Bone Loss in Patients With Diabetes Mellitus
NCT00933491
Effects of Earplugs on Sleep and Sleep Apnea
NCT01062854
Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality
NCT00782795
Effects of Fish Oil on Post Ablation Arrhythmias
NCT00791089
Seasonal Influenza Vaccination Reminders for Children With High-risk Conditions
NCT01431183
Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects
NCT00815854
Micronutrients to Prevent Noise-induced Hearing Loss
NCT00808470
Diffusion Tensor Imaging of Sural Nerves in Diabetic Peripheral Neuropathy
NCT00835757
PET Study of Non-Motor Symptoms of Parkinson Disease
NCT01565473
Differentiating Recurrent Brain Tumor Versus Radiation Injury Using MRI
NCT00760409
P300 Brain Computer Interface Keyboard to Operate Assistive Technology
NCT00860951
Does Fish Oil Prevent Depression in Pregnancy and Postpartum?
NCT00711971
Community Approaches to Cardiovascular Health: Pathways to Heart Health
NCT02036593
Intraoperative Glucose Control in Liver Transplant
NCT00780026
Chamomile for Chronic Primary Insomnia
NCT01286324
Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury
NCT00735670
Developing Biomarkers for Fibromyalgia
NCT00932061
Evaluation of Exenatide in Patients With Diabetic Neuropathy
NCT00855439
Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy
NCT00755911
The Pathogenesis of Idiopathic Dry Eyes
NCT01254201
The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy
NCT00696410
Bispectral Index (BIS) Versus Electronic Alerts in the Prevention of Anesthesia Awareness: the Michigan Awareness Control Study
NCT00689091
Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)
NCT00809224
Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria
NCT00625820
Initial Versus Delayed Operation for Treatment of Complicated Appendicitis In Children
NCT00540189
Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus
NCT00730002
Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder
NCT00872131
Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis
NCT00667134
Sonographic Features of Normal Soft Tissues of the Feet
NCT00719004
Anesthesia and Functional Connectivity: An Analysis of fMRI Changes
NCT02196259
Upright Versus Supine Exercise Testing in Fontan-palliated Patients
NCT00633815
Expression of Angiogenic Biomarkers During Healing of Intra-Oral Soft Tissue Engineered Grafts
NCT01134081
Study of Brain Function in Women With Insulin Resistant Polycystic Ovary Syndrome
NCT00670800
The Influence of Dimensional Anatomic Variables on the Outcomes of Maxillary Sinus Grafting Procedures
NCT00868777
Breast Lesion Analysis for Tomosynthesis Mammography
NCT00723541
Evaluating Outcomes in the Placement of Boomerang Percutaneous Device
NCT00732628
The Women's Healthy Lifestyle Study
NCT00583726
Neovascularization Patterns in Corneal Graft Rejection
NCT01695655
PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
NCT00554853
Self-Care to Prevent Birth-Related Urinary Incontinence in Diverse Women
NCT00763984
Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus
NCT00844077
Age-Specific Strategies for Immunization Reminders and Recalls
NCT01770496
Femtosecond Laser Assisted Keratoplasty
NCT00802776
A System for Lengthening Contraction Training of Muscle
NCT00575107
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.